Victrex plc (LON:VCT – Get Rating) declared a dividend on Monday, May 9th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, May 26th will be given a dividend of GBX 13.42 ($0.17) per share on Wednesday, June 29th. This represents a yield of 0.75%. The ex-dividend date of this dividend is Thursday, May 26th. The official announcement can be accessed at this link.
Victrex stock opened at GBX 1,736 ($21.69) on Monday. The firm has a market cap of £1.51 billion and a PE ratio of 20.30. The company has a debt-to-equity ratio of 3.11, a quick ratio of 2.72 and a current ratio of 4.24. The firm’s 50 day moving average price is GBX 1,839.02 and its two-hundred day moving average price is GBX 2,109.85. Victrex has a twelve month low of GBX 1,635 ($20.42) and a twelve month high of GBX 2,720 ($33.98).
In other news, insider Brendan Connolly acquired 500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 22nd. The stock was acquired at an average cost of GBX 1,920 ($23.99) per share, with a total value of £9,600 ($11,992.50). Also, insider Jakob Sigurdsson acquired 2,800 shares of the firm’s stock in a transaction that occurred on Monday, February 21st. The shares were purchased at an average cost of GBX 1,893 ($23.65) per share, with a total value of £53,004 ($66,213.62). In the last 90 days, insiders have bought 3,324 shares of company stock worth $6,305,472.
Victrex Company Profile (Get Rating)
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.
- Skechers Stock Can Be Bought on Pullbacks
- ChemoCentryx: A Biotech Stock Well Worth the Risk
- Nasdaq Stock is a Buy the (Deep) Dip Opportunity
- Three Stocks To Ride Out A Rough Market
- MarketBeat: Week in Review 5/2 – 5/6
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.